4th Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$2,360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

16 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Drug Importation ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---S.Con.Res. 25: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2018 and setting forth the appropriate budgetary levels for fiscal years 2019 through 2027 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Intellectual Property International Enforcement ---Compulsory Licensing ---India International IP Patent Law Harmonization North American Free Trade Agreement (NAFTA) Renegotiation ---Ag-Biotech Provisions ---IP Provisions ---Pricing and Reimbursement Provisions Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); White House Office; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); SENATE; Office of Management & Budget (OMB); Natl Economic Council (NEC); Food & Drug Administration (FDA)

Bills named: S. 469 (115th), S. 1603 (115th), S. 771 (115th), H.R. 3268 (115th), S.Con.Res. 25 (115th), S. 1771 (115th), H.R. 3358 (115th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Farm Bill Reauthorization ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Sen. Grassley Amendment #11 to H.R. 1: Tax Cuts & Job Act Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program Funding for Biofuels ---Farm Bill Reauthorization ---H.R. 3266/S.1609: Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biomass Crop Assistance Program ---Farm Bill Reauthorization ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biorefineries ---Farm Bill Reauthorization ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---Notice of Data Availability (NODA) Related to 2018 RFS Volumes ---Proposed Rule for 2018 Volumes ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Natl Security Council (NSC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); SENATE; White House Office; Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Defense, Dept of (DOD)

Bills named: H.R. 3266 (115th), S. 517 (115th), H.R. 4118 (115th), H.R. 1 (115th), H.R. 1311 (115th), S. 1603 (115th), S. 1609 (115th), H.R. 3268 (115th), S. 2005 (115th)

Health Issues HCR

340B Drug Discount Program ---340B Program Reforms (Rep. C. Collins Discussion Draft) ---Program Implementation & Oversight ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 4710: 340B Pause Act Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) Biosimilars ---S. 974/H.R. 2212: CREATES Act of 2017 ---Access to Samples Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Innovation Incentives ---Patient-Focused Drug Development ---S.204 / H.R. 878: Right to Try Act of 2017 ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---Biosimilar User Fee Amendments (BSUFA) II Implementation Drug Importation ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---S.Con.Res. 25: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2018 and setting forth the appropriate budgetary levels for fiscal years 2019 through 2027 Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight Drug Pricing ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs Drug Product Communications ---H.R. 1703: The Medical Products Communications Act ---H.R. 2026: Pharmaceutical Information Exchange Act Funding for Antimicrobial Resistance Programs ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act ---H.R. 749: Lower Drug Costs through Competition Act ---S. 974/H.R. 2212: CREATES Act of 2017 Independent Payment Advisory Board Repeal ---H.R. 849/S. 260: Protecting Seniors' Access to Medicare Act Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Section 1115 Waivers North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis Orphan Drug Issues ---Technical Amendments ---Tax Credit ---H.R. 1: Tax Cuts & Jobs Act Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---H.R. 242: Medicare Prescription Drug Price Negotiation Act ---H.R. 4138: Medicare Drug Price Negotiation Act Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education

Contacted: SENATE; Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); White House Office; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Natl Economic Council (NEC); Securities & Exchange Commission (SEC)

Bills named: H.R. 3358 (115th), H.R. 849 (115th), S. 771 (115th), S. 974 (115th), S. 1688 (115th), H.R. 1 (115th), S. 204 (115th), S. 1369 (115th), S. 1771 (115th), S. 469 (115th), H.R. 2212 (115th), H.R. 1703 (115th), H.R. 4710 (115th), H.R. 3219 (115th), S.Con.Res. 25 (115th), H.R. 297 (115th), H.R. 749 (115th), S. 1603 (115th), H.R. 2026 (115th), S. 260 (115th), S. 1348 (115th), H.R. 2974 (115th), H.R. 3268 (115th), S. 637 (115th), H.R. 4138 (115th), H.R. 242 (115th), H.R. 878 (115th)

Agriculture AGR

Agricultural Education Policy Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Funding for Biomass Crop Assistance Program ---Farm Bill Reauthorization ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for the USDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Genetically Engineered (GE) Animals ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---The One Health Act (Sen. Franken Discussion Draft) ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ------Amendment on GE Salmon Labeling North American Free Trade Agreement (NAFTA) Renegotiation ---Ag-Biotech Provisions One Health ---The One Health Act (Sen. Franken Discussion Draft) Potential Regulation of New Genetic Modification Technologies Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Farm Bill Reauthorization ---Potential Revisions to Part 340 Regulations

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS New —
KYLE KUNKLER —
SARAH KYLE —
JORDAN LAYSON —
ERICK LUTT —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
RINA SINGH —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); White House Office; Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); SENATE; Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3268 (115th), S. 1603 (115th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Sen. Grassley Amendment #11 to H.R. 1: Tax Cuts & Jobs Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Capital Formation Investment Incentives ---An Act to Modify Net Operating Loss Carryforwards (House Discussion Draft) ---H.R. 2297: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules Corporate Tax Reform ---H.R. 1: Tax Cuts & Jobs Act Orphan Drug Issues ---Tax Credit ---H.R. 1: Tax Cuts & Jobs Act Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Investment Tax Credit ---Production Tax Credit ---HR 3149/S. 1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Research & Development Tax Credit Reforms ---Extension ---Permanency ---Refundable R&D Credit ---H.R. 1: Tax Cuts & Jobs Act

LobbyistCovered position, as disclosed
CAMERON ARTERTON New —
TAYLOR BOOTH —
CHARLES CRAIN —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
JEANNE HAGGERTY —
ERICK LUTT —
RINA SINGH —

Contacted: SENATE; Defense, Dept of (DOD); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); White House Office; U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Natl Security Council (NSC)

Bills named: H.R. 2297 (115th), H.R. 3149 (115th), S. 1980 (115th), S. 2005 (115th), H.R. 1 (115th), H.R. 4118 (115th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---March-In Rights -------H.R. 2810: National Defense Authorization Act of 2018 Intellectual Property International Enforcement ---Compulsory Licensing ---India Inter Partes Review ---Implementation of the America Invents Act of 2011 ---S. 1390: STRONGER Patents Act ---Sovereign Immunity International IP Patent Law Harmonization North American Free Trade Agreement (NAFTA) Renegotiation ---IP Provisions Nomination of Under Secretary of Commerce for Intellectual Property Patent Reform ---Patent Litigation Reforms ---S. 1390: STRONGER Patents Act Patenting of Biological Inventions ---Section 101 Modernization UN High Level Commission on Access to Medicines ---IP Proposals

Contacted: Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); White House Office; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Natl Economic Council (NEC)

Bills named: S. 1390 (115th), H.R. 2810 (115th)

Small Business SMB

Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions Proxy Advisory Services ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption Short Selling Transparency XBRL Exemption for Small Public Companies ---Small Company Disclosure Simplification Act (House Discussion Draft)

LobbyistCovered position, as disclosed
CHARLES CRAIN —
ELIZABETH CARTIER ESHAM —
JEANNE HAGGERTY —
DAVID LACHMANN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); White House Office; Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Natl Security Council (NSC); Natl Institutes of Health (NIH); SENATE; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 4015 (115th), S. 2126 (115th), H.R. 1645 (115th)

Medicare/Medicaid MMM

Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Section 1115 Waivers Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---Value-based Contracting and Communications ---H.R. 242: Medicare Prescription Drug Price Negotiation Act ---H.R. 4138: Medicare Drug Price Negotiation Act

LobbyistCovered position, as disclosed
TAYLOR BOOTH —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Natl Security Council (NSC); SENATE; White House Office; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR)

Bills named: H.R. 4138 (115th), H.R. 242 (115th), S. 771 (115th), S. 1688 (115th)

Budget/Appropriations BUD

Funding for Antimicrobial Resistance Programs ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biofuels ---Farm Bill Reauthorization ---H.R. 3266/S.1609: Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biomass Crop Assistance Program ---Farm Bill Reauthorization ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biorefineries ---Farm Bill Reauthorization ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Renewable Chemicals/Bio-based Products ---Farm Bill Reauthorization ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R.2810: National Defense Authorization Act of 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the USDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
TAYLOR BOOTH —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
DAN JENKINS New —
KYLE KUNKLER —
SARAH KYLE —
JORDAN LAYSON —
ERICK LUTT —
RINA SINGH —
PHI D VU —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA); Natl Economic Council (NEC); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); White House Office; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Defense, Dept of (DOD)

Bills named: H.R. 2810 (115th), H.R. 3219 (115th), H.R. 3266 (115th), H.R. 3268 (115th), S. 1603 (115th), S. 1609 (115th), H.R. 3358 (115th), S. 1771 (115th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
TAYLOR BOOTH —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —
PHI D VU —

Contacted: Natl Economic Council (NEC); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Health Resources & Services Administration (HRSA); SENATE; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3219 (115th), S. 1771 (115th), H.R. 3358 (115th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---Farm Bill Reauthorization ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 2810: National Defense Authorization Act of 2018 Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Investment Tax Credit ---Production Tax Credit ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---Farm Bill Reauthorization ---H.R. 3149/S.1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S.2005: Master Limited Partnership Parity Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3268 (115th), H.R. 4118 (115th), S. 2005 (115th), H.R. 3149 (115th), S. 1980 (115th), S. 1603 (115th), H.R. 2810 (115th)

Consumer Issues/Safety/Products CSP

Drug Importation ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S.Con.Res. 25: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2018 and setting forth the appropriate budgetary levels for fiscal years 2019 through 2027 Genetically Engineered (GE) Animals ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---The One Health Act (Sen. Franken Discussion Draft) ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ------Amendment on GE Salmon Labeling Opioid Crisis Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: SENATE; Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); White House Office; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Economic Council (NEC); Natl Institutes of Health (NIH)

Bills named: H.R. 3268 (115th), S. 771 (115th), S. 1771 (115th), S.Con.Res. 25 (115th), S. 469 (115th), S. 1603 (115th), H.R. 3358 (115th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---The One Health Act (Sen. Franken Discussion Draft) ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 --------Amendment on GE Salmon Labeling Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS New —
KYLE KUNKLER —
JORDAN LAYSON —
DANA MAURICE O'BRIEN —

Contacted: Natl Institutes of Health (NIH); White House Office; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC)

Bills named: S. 1603 (115th), H.R. 3268 (115th)

Animals ANI

Genetically Engineered (GE) Animals ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---The One Health Act (Sen. Franken Discussion Draft) ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ------Amendment on GE Salmon Labeling

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
JEANNE HAGGERTY —
DAN JENKINS New —
KYLE KUNKLER —
JORDAN LAYSON —
DANA MAURICE O'BRIEN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Natl Institutes of Health (NIH); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); White House Office; Defense, Dept of (DOD); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 3268 (115th), S. 1603 (115th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Farm Bill Reauthorization ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Sen. Grassley Amendment #11 to H.R. 1: Tax Cuts & Job Act Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program Funding for Biofuels ---Farm Bill Reauthorization ---H.R. 3266/S.1609: Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biomass Crop Assistance Program ---Farm Bill Reauthorization ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for Biorefineries ---Farm Bill Reauthorization ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---Notice of Data Availability (NODA) Related to 2018 RFS Volumes ---Proposed Rule for 2018 Volumes ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
CHARLES H FRITTS —
JEANNE HAGGERTY —
KYLE KUNKLER —
ERICK LUTT —
RINA SINGH —

Contacted: SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Defense, Dept of (DOD); White House Office; Natl Security Council (NSC); Natl Economic Council (NEC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: H.R. 1311 (115th), H.R. 4118 (115th), S. 2005 (115th), S. 1609 (115th), H.R. 1 (115th), S. 517 (115th), S. 1603 (115th), H.R. 3266 (115th), H.R. 3268 (115th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) Funding for Antimicrobial Resistance Programs ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018

LobbyistCovered position, as disclosed
HAYLEY B ALEXANDER —
PHYLLIS ARTHUR —
TAYLOR BOOTH —
JAMIE GREGORIAN —
JEANNE HAGGERTY —
SARAH KYLE —
JORDAN LAYSON —
PHI D VU —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Defense, Dept of (DOD); White House Office; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Natl Security Council (NSC); Natl Economic Council (NEC)

Bills named: H.R. 3358 (115th), S. 1603 (115th), S. 1771 (115th), H.R. 3268 (115th), H.R. 3219 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.